期刊
OPHTHALMOLOGY
卷 126, 期 8, 页码 1181-1188出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.ophtha.2019.03.018
关键词
-
资金
- Instituto de Salud Carlos III (ISCIII) of the Spanish Ministry of Health
- Center for Biomedical Research Network on Rare Diseases [CIBERER 06/07/0036]
- FIS [PI16/00425]
- IIS-FJD Biobank [PT13/0010/0012]
- Regional Government of Madrid (CAM) [B2017/BMD37]
- FEDER (European Regional Development Fund)
- Spanish National Organization for the Blind (ONCE)
- Spanish Fighting Blindness Foundation (FUNDALUCE)
- University Chair UAM-IIS-FJD of Genomic Medicine
- Ramon Areces Foundation
Purpose: We aimed to unravel the molecular basis of sporadic retinitis pigmentosa (sRP) in the largest cohort reported to date. Design: Case series. Participants: A cohort of 877 unrelated Spanish sporadic cases with a clinical diagnosis of retinitis pigmentosa (RP) and negative family history. Methods: The cohort was studied by classic genotyping or targeted next-generation sequencing (NGS). Multiplex ligation-dependent probe amplification (MLPA) and array-based comparative genomic hybridization were performed to confirm copy number variations detected by NGS. Quantitative fluorescent polymerase chain reaction was assessed in sRP cases carrying de novo variants to confirm paternity. Main Outcome Measures: The study of the sRP cohort showed a high proportion of causal autosomal dominant (AD) and X-linked (XL) variants, most of them being de novo. Results: Causative variants were identified in 38% of the patients studied, segregating recessively in 84.5% of the solved cases. Biallelic variants detected in only 6 different autosomal recessive genes explained 50% of the cases characterized. Causal AD and XL variants were found in 7.6% and 7.9% of cases, respectively. Remarkably, 20 de novo variants were confirmed after trio analysis, explaining 6% of the cases. In addition, 17% of the solved sRP cases were reclassified to a different retinopathy phenotype. Conclusions: This study highlights the clinical utility of NGS testing for sRP cases, expands the mutational spectrum, and provides accurate prevalence of mutated genes. Our findings evidence the underestimated role of de novo variants in the etiology of RP, emphasizing the importance of segregation analysis as well as comprehensive screening of genes carrying XL and AD variants in sporadic cases. Such in-depth study is essential for accurate family counseling and future enrollment in gene therapy-based treatments. (C) 2019 by the American Academy of Ophthalmology
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据